| 1. Bierer DE, Dubenko LG, Zhang P, Lu Q, Imbach PA, Garofalo AW, Phuan PW, Fort DM, Litvak J, Gerber RE, Sloan B, Luo J, Cooper R, Reaven GM.. (1998) Antihyperglycemic activities of cryptolepine analogues: an ethnobotanical lead structure isolated from Cryptolepis sanguinolenta., 41 (15): [PMID:9667966] [10.1021/jm970735n] |
| 2. Bierer DE, Fort DM, Mendez CD, Luo J, Imbach PA, Dubenko LG, Jolad SD, Gerber RE, Litvak J, Lu Q, Zhang P, Reed MJ, Waldeck N, Bruening RC, Noamesi BK, Hector RF, Carlson TJ, King SR.. (1998) Ethnobotanical-directed discovery of the antihyperglycemic properties of cryptolepine: its isolation from Cryptolepis sanguinolenta, synthesis, and in vitro and in vivo activities., 41 (6): [PMID:9526563] [10.1021/jm9704816] |
| 3. Arzel E, Rocca P, Grellier P, Labaeïd M, Frappier F, Guéritte F, Gaspard C, Marsais F, Godard A, Quéguiner G.. (2001) New synthesis of benzo-delta-carbolines, cryptolepines, and their salts: in vitro cytotoxic, antiplasmodial, and antitrypanosomal activities of delta-carbolines, benzo-delta-carbolines, and cryptolepines., 44 (6): [PMID:11300877] [10.1021/jm0010419] |
| 4. Onyeibor O, Croft SL, Dodson HI, Feiz-Haddad M, Kendrick H, Millington NJ, Parapini S, Phillips RM, Seville S, Shnyder SD, Taramelli D, Wright CW.. (2005) Synthesis of some cryptolepine analogues, assessment of their antimalarial and cytotoxic activities, and consideration of their antimalarial mode of action., 48 (7): [PMID:15801861] [10.1021/jm040893w] |
| 5. Olajide OA, Heiss EH, Schachner D, Wright CW, Vollmar AM, Dirsch VM.. (2007) Synthetic cryptolepine inhibits DNA binding of NF-kappaB., 15 (1): [PMID:17064915] [10.1016/j.bmc.2006.10.018] |
| 6. Seville S, Phillips RM, Shnyder SD, Wright CW.. (2007) Synthesis of cryptolepine analogues as potential bioreducible anticancer agents., 15 (19): [PMID:17643990] [10.1016/j.bmc.2007.06.062] |
| 7. Lavrado J, Paulo A, Gut J, Rosenthal PJ, Moreira R.. (2008) Cryptolepine analogues containing basic aminoalkyl side-chains at C-11: synthesis, antiplasmodial activity, and cytotoxicity., 18 (4): [PMID:18207399] [10.1016/j.bmcl.2008.01.015] |
| 8. Cimanga K, De Bruyne T, Pieters L, Vlietinck AJ, Turger CA.. (1997) In vitro and in vivo antiplasmodial activity of cryptolepine and related alkaloids from Cryptolepis sanguinolenta., 60 (7): [PMID:9249972] [10.1021/np9605246] |
| 9. Yang SW, Abdel-Kader M, Malone S, Werkhoven MC, Wisse JH, Bursuker I, Neddermann K, Fairchild C, Raventos-Suarez C, Menendez AT, Lane K, Kingston DG.. (1999) Synthesis and biological evaluation of analogues of cryptolepine, an alkaloid isolated from the Suriname rainforest., 62 (7): [PMID:10425120] [10.1021/np990035g] |
| 10. Acharya BN, Saraswat D, Kaushik MP.. (2008) Pharmacophore based discovery of potential antimalarial agent targeting haem detoxification pathway., 43 (12): [PMID:18395298] [10.1016/j.ejmech.2008.02.005] |
| 11. Van Miert S, Hostyn S, Maes BU, Cimanga K, Brun R, Kaiser M, Mátyus P, Dommisse R, Lemière G, Vlietinck A, Pieters L.. (2005) Isoneocryptolepine, a synthetic indoloquinoline alkaloid, as an antiplasmodial lead compound., 68 (5): [PMID:15921407] [10.1021/np0496284] |
| 12. Van Baelen G, Hostyn S, Dhooghe L, Tapolcsányi P, Mátyus P, Lemière G, Dommisse R, Kaiser M, Brun R, Cos P, Maes L, Hajós G, Riedl Z, Nagy I, Maes BU, Pieters L.. (2009) Structure-activity relationship of antiparasitic and cytotoxic indoloquinoline alkaloids, and their tricyclic and bicyclic analogues., 17 (20): [PMID:19781948] [10.1016/j.bmc.2009.08.057] |
| 13. Bonazzi S, Barbaras D, Patiny L, Scopelliti R, Schneider P, Cole ST, Kaiser M, Brun R, Gademann K.. (2010) Antimalarial and antitubercular nostocarboline and eudistomin derivatives: synthesis, in vitro and in vivo biological evaluation., 18 (4): [PMID:20133138] [10.1016/j.bmc.2010.01.013] |
| 14. Rojas M, Wright CW, Piña B, Portugal J.. (2008) Genomewide expression profiling of cryptolepine-induced toxicity in Saccharomyces cerevisiae., 52 (11): [PMID:18710911] [10.1128/aac.00532-08] |
| 15. Lavrado J, Cabal GG, Prudêncio M, Mota MM, Gut J, Rosenthal PJ, Díaz C, Guedes RC, dos Santos DJ, Bichenkova E, Douglas KT, Moreira R, Paulo A.. (2011) Incorporation of basic side chains into cryptolepine scaffold: structure-antimalarial activity relationships and mechanistic studies., 54 (3): [PMID:21207937] [10.1021/jm101383f] |
| 16. Lavrado J, Mackey Z, Hansell E, McKerrow JH, Paulo A, Moreira R.. (2012) Antitrypanosomal and cysteine protease inhibitory activities of alkyldiamine cryptolepine derivatives., 22 (19): [PMID:22926067] [10.1016/j.bmcl.2012.07.104] |
| 17. Olajide OA, Bhatia HS, de Oliveira AC, Wright CW, Fiebich BL.. (2013) Anti-neuroinflammatory properties of synthetic cryptolepine in human neuroblastoma cells: possible involvement of NF-κB and p38 MAPK inhibition., 63 [PMID:23507189] [10.1016/j.ejmech.2013.02.004] |
| 18. Chadha N, Silakari O.. (2017) Indoles as therapeutics of interest in medicinal chemistry: Bird's eye view., 134 [PMID:28412530] [10.1016/j.ejmech.2017.04.003] |
